parp inhibitors in ovarian cancer: clinical updates from sgo 2023
Published 1 year ago • 2.2K plays • Length 59:14Download video MP4
Download video MP3
Similar videos
-
59:02
parp inhibitors as first-line maintenance therapy in ovarian cancer
-
35:35
maximizing the potential of parp inhibitors as first-line maintenance therapy in ovarian cancer
-
9:47
can parp inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
-
3:45
parp inhibitors for ovarian cancer
-
58:12
enhancing personalized medicine in ovarian cancer: advances in parp inhibition and novel modalities
-
2:58
standard of care updates in ovarian cancer: parp inhibitors
-
1:10:07
optimizing the use of parp inhibitors in ovarian cancer
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
15:43
clinical data with parp inhibitors in ovarian cancer
-
3:05
an overview of parp inhibitors in ovarian cancer
-
4:12
parp inhibitors
-
1:24
innovations in ovarian cancer treatment: parp inhibitors
-
34:36
parp inhibitors with johnathan lederman
-
6:20
parp inhibitors in recurrent ovarian cancer
-
50:29
the parp revolution: how parp inhibitors are changing the landscape of ovarian cancer treatment
-
1:06:27
parp & clinical trial advances in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
4:14
parp inhibition in ovarian cancer: what’s next?